2 completed, 1 terminated. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 2, Terminated 1 |
Follow Postmenopausal: new trials by email Literature Review of Postmenopausal trials Research Report on Postmenopausal
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Efficacy and Safety of HLX14 vs. Denosumab Prolia® in Postmenopausal Women With Osteoporosis at High Risk of Fracture HLX14, Prolia® - Postmenopausal | Phase 3 | Completed | Shanghai Henlius Biotech | 514 | 2022-06-17 | 2024-09-20 |
| Effects of Whole Body Vibration on Postmenopausal Risk-factors in Elderly Women vertical vibration device (Vibrafit whole body vibration platform), side alternating vibration device (Board 3000 whole body vibration platform), stretching and wellness (control group) - Postmenopausal | Phase 3 | Terminated | University of Erlangen-Nürnberg Medical School | 108 | 2008-04-01 | 2015-05-28 |
| Safety/Efficacy of Letrozole Monotherapy or in Combination With Zoledronic Acid as Extended Adjuvant Treatment of Postmenopausal Patients With Primary Breast Cancer Letrozole, Zoledronic acid - Osteoporosis, Postmenopausal | Phase 3 | Completed | Novartis | 83 | 2006-01-01 | 2011-11-16 |
Breast Neoplasms (1) · Motor Activity (1) · Osteoporosis (1)
Behavior (1) · Bone Diseases (1) · Bone Diseases, Metabolic (1) · Breast Diseases (1) · Metabolic Diseases (1) · Musculoskeletal Diseases (1) · Neoplasms (1) · Neoplasms by Site (1) · Nutritional and Metabolic Diseases (1) · Skin Diseases (1) · Skin and Connective Tissue Diseases (1)
Control Groups (1) · Denosumab (1) · Health (1) · Letrozole (1) · Zoledronic Acid (1)
Novartis (1) · Shanghai Henlius Biotech (1) · University of Erlangen-Nürnberg Medical School (1)
Germany (2) · China (1)
Simon O von Stengel, PhD (1) · Willi A Kalender, Prof., PhD (1) · Wolfgang K Kemmler, PhD (1)